STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture
Clinical Investigation of a Local Osteo-Enhancement Procedure's (LOEP) Ability to Strengthen the Contralateral Femur of Women After a Fragility Fracture of the Hip in Hong Kong
Sponsor: AgNovos Healthcare, LLC
This NA trial investigates Hip Fractures and Osteoporosis, Postmenopausal and is currently completed. AgNovos Healthcare, LLC leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2022 — Jul 2024 [monthly]
Completed NA
-
Sep 2022 — Dec 2022 [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Jul 2022 — Sep 2022 [monthly]
Withheld
▶ Show 7 earlier versions
-
Mar 2022 — Jul 2022 [monthly]
Withheld
-
Dec 2021 — Mar 2022 [monthly]
Withheld
-
Jan 2021 — Dec 2021 [monthly]
Withheld
-
Nov 2020 — Jan 2021 [monthly]
Withheld
-
Mar 2019 — Nov 2020 [monthly]
Withheld
-
Apr 2018 — Mar 2019 [monthly]
Withheld
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Withheld NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AgNovos Healthcare, LLC
For direct contact, visit the study record on ClinicalTrials.gov .